New And Upcoming Studies

  • IN PIPELINE

  • EBV Saliva study in collaboration with the Blizzard Institute, London, UK.
    QSM Imaging study in collaboration with Weill Cornell Medical Center, NY.

 


    • NOW ENROLLING- PRIMARY PROGRESSIVE COHORT

      Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants with Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)                             (Sponsor: Genentech)

      This is an open-label, multicenter, biomarker study designed to be hypothesis-generating in order to better understand the mechanism of action of ocrelizumab and B-cell biology in patients with Relapsing MS or Primary Progressive MS.

      For more information, please contact Judy O’Connor/Jessica Siuta at 518-785-1000
      (OR)
      RESEARCH LINE at 518-703-0695

Click here for more information from ClinicalTrials website


  • Interested in participating in any of our clinical trials, please complete this Contact Form